A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease
Clinical trial NCT02140554 · COMPLETED
Trial details
- NCT number
- NCT02140554
- Sponsor
- Genetix Biotherapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-02
- Primary completion
- 2023-07-31
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.